The presence of CSF or plasma amyloid and p-tau 181 or 217 (mostly p-tau 217) has been considered as sensitive and specific to AD with Nfl and GFAP as important non-specific AD biomarkers. The gene discussed is GFAP; the disease is Alzheimer disease.